Treatment of filarial diseases
AssigneesLiverpool School of Tropical Medicine, AbbVie Inc.
InventorsThomas W. Von Geldern, Dale J. Kempf, Kennan C. Marsh, Mark John Taylor, Stephen Andrew Ward, Louise Ford, Joseph Turner
Life of this patent
Estimating the term…
Abstract
The present invention pertains to prevention of and/or treatment for filariasis. In particular, the present invention pertains to the use of tylosin A and its analogs and derivatives to prevent or treat filarial worm infection and/or diseases associated with filarial worm infection. The present invention also pertains to pharmaceutical compositions comprising tylosin A or an analog or derivative thereof for use in preventing or treating filarial worm infection and/or diseases associated with filarial worm infection.
Claims28
A method of preventing or treating filariasis in a subject in need thereof, comprising:
- administering to the subject a therapeutically effective amount of tylosin A or a salt thereof.
A method of preventing or treating filariasis caused by Onchocerca volvulus, Wuchereria bancrofti, Brugia malayi, Brugia timori, or Dirofilaria immitis in a subject in need thereof, comprising:
- administering to the subject a therapeutically effective amount of a compound of Formula (I):
- or a salt thereof, wherein:
- R1 represents hydrogen or —C(O)R3, wherein R3 represents an optionally substituted C1-C6-alkyl or C1-C6-haloalkyl;
- R2 represents —C(O)C(R4)(R5)(R6), wherein R4is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, aryl, heteroaryl, C3-C8-cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, and C3-C8-cycloalkyl C1-C4-alkyl;
- and each of R5 and R6 are independently selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, aryl, heteroaryl, C3-C8-cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, and C3-C8-cycloalkyl -C1- C4-alkyl;
- or
- R2 represents —C(O)N(R7)(R8), wherein each of R7 and R8 are independently selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, aryl, heteroaryl, C3-C8-cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, and C3-C8-cycloalkyl -C1- C4-alkyl, or R7 and R8 together with the nitrogen atom to which they are attached form an optionally substituted saturated or partially saturated heterocyclic ring;
- or
- R2 represents —CH2-A1 , wherein A1 represents a 6-to 10-membered aryl or a 5-to 10-membered heteroaryl and A1 is unsubstituted or substituted with one or more RA, wherein each RA is independently selected from the group consisting of halogen, C1-C6-alkyl, C1-C6-haloalkyl, and —O —R9, where R9 represents C1-C6-alkyl;
- R10 represents hydrogen or —C(O)R11, wherein R11 represents an optionally substituted C1-C6-alkyl, C1-C6-haloalkyl, aryl, heteroaryl, C3-C8-cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, or C3-C8-cycloalkyl —C1- C4-alkyl;
- and
- each of a and b independently represents either a single bond or a double bond.
A method of preventing or treating filariasis caused by Onchocerca volvulus, Wuchereria bancrofti, Brugia malayi, Brugia timori, or Dirofilaria immitis in a subject in need thereof, comprising:
- administering to the subject a therapeutically effective amount of a compound of Formula (III):
- or a salt thereof, wherein:
- R1 represents hydrogen or —C(O)R3, where R3 represents C1-C6-alkyl;
- A1 represents a 6 -to 10-membered aryl or a 5 -to 10-membered heteroaryl and A1 is unsubstituted or substituted with one or more RA, wherein each RA is independently selected from the group consisting of halogen, C1-C6-alkyl, C1-C6-haloalkyl, and —O —R9,where R9represents C1-C6-alkyl;
- and
- each of a and b independently represents either a single bond or a double bond.
Dependencies are inferred from the claim text.